PTEN mutations in gliomas and glioneuronal tumors
The DOI matches its Crossref record.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism
Engelman, J. A., Luo, J., & Cantley, L. C. (2006) · Nature Reviews Genetics · doi:10.1038/nrg1879 · Cited by 3,330
Applying the principles of stem-cell biology to cancer
Pardal, R., Clarke, M. F., & Morrison, S. J. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1232 · Cited by 1,624
The Biology and Clinical Relevance of the PTEN Tumor Suppressor Pathway
Sansal, I., & Sellers, W. R. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.02.141 · Cited by 921
PTEN: One Gene, Many Syndromes
Eng, C. (2003) · Human Mutation · doi:10.1002/humu.10257 · Cited by 787
Self-citationUbiquitination regulates PTEN nuclear import and tumor suppression
Trotman, L. C., Wang, X., Alimonti, A., Chen, Z., Teruya-Feldstein, J., Yang, H., Pavletich, N. P., Carver, B. S., Cordon-Cardo, C., Erdjument-Bromage, H., et al. (2007) · Cell · doi:10.1016/j.cell.2006.11.040 · Cited by 748
“Strikingly, K13 of PTEN is also found mutated to glutamic acid (K13E) in spontaneous cancer (Duerr et al., 1998).”
BackgroundPTEN: Life as a Tumor Suppressor
Simpson, L., & Parsons, R. (2001) · Experimental Cell Research · doi:10.1006/excr.2000.5130 · Cited by 679
Self-citationDiffuse glioma growth: a guerilla war
Claes, A., Idema, A. J., & Wesseling, P. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0293-7 · Cited by 636
Primary and secondary glioblastomas: From concept to clinical diagnosis
Kleihues, P., & Ohgaki, H. (1999) · Neuro-Oncology · doi:10.1093/neuonc/1.1.44 · Cited by 586
Ishii, N., Maier, D., Merlo, A., Tada, M., Sawamura, Y., Diserens, A., & Van Meir, E. G. (1999) · Brain Pathology · doi:10.1111/j.1750-3639.1999.tb00536.x · Cited by 569
“While the frequency of PTEN mutation in the cell lines analyzed was significantly higher than that found in glioblastoma (17-44%; average on 451 tumors: 24%), the mutation spectrum of this gene was similar between glioma cell lines and tissue (7, 10, 11, 23, 24, 35, 37, 40, 41, 44).”
BackgroundResultRong, Y., Durden, D. L., Van Meir, E. G., & Brat, D. J. (2006) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-200606000-00001 · Cited by 567
Mutational Spectra of PTEN/MMAC1 Gene: a Tumor Suppressor With Lipid Phosphatase Activity
Ali, I. U., Schriml, L. M., & Dean, M. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.22.1922 · Cited by 542
Worby, C. A., & Dixon, J. E. (2014) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-082411-113907 · Cited by 535
Clinical, Cellular, and Molecular Aspects of Cancer Invasion
Mareel, M., & Leroy, A. (2003) · Physiological Reviews · doi:10.1152/physrev.00024.2002 · Cited by 524
Ligon, K. L., Huillard, E., Mehta, S., Kesari, S., Liu, H., Alberta, J. A., Bachoo, R. M., Kane, M., Louis, D. N., DePinho, R. A., et al. (2007) · Neuron · doi:10.1016/j.neuron.2007.01.009 · Cited by 501
Self-citationPTEN and Myotubularin: Novel Phosphoinositide Phosphatases
Maehama, T., Taylor, G. S., & Dixon, J. E. (2001) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.70.1.247 · Cited by 461
Dazert, E., & Hall, M. N. (2011) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2011.09.003 · Cited by 460
Pilocytic astrocytoma: pathology, molecular mechanisms and markers
Collins, V. P., Jones, D. T. W., & Giannini, C. (2015) · Acta Neuropathologica · doi:10.1007/s00401-015-1410-7 · Cited by 445
Gangliogliomas: An Intriguing Tumor Entity Associated With Focal Epilepsies
Blümcke, I., & Wiestler, O. D. (2002) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/61.7.575 · Cited by 378
Self-citationPerren, A., Weng, L.-P., Boag, A. H., Ziebold, U., Thakore, K., Dahia, P. L. M., Komminoth, P., Lees, J. A., Mulligan, L. M., Mutter, G. L., et al. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65227-3 · Cited by 378
Self-citationThe role of PTEN signaling perturbations in cancer and in targeted therapy
Keniry, M., & Parsons, R. (2008) · Oncogene · doi:10.1038/onc.2008.248 · Cited by 358
Self-citationAngiogenesis in Gliomas: Biology and Molecular Pathophysiology
Fischer, I., Gagner, J., Law, M., Newcomb, E. W., & Zagzag, D. (2005) · Brain Pathology · doi:10.1111/j.1750-3639.2005.tb00115.x · Cited by 350
Targeting cellular pathways in glioblastoma multiforme
Pearson, J. R. D., & Regad, T. (2017) · Signal Transduction and Targeted Therapy · doi:10.1038/sigtrans.2017.40 · Cited by 344
Mutations of the human PTEN gene
Bonneau, D., & Longy, M. (2000) · Human Mutation · doi:10.1002/1098-1004(200008)16:2<109::aid-humu3>3.0.co;2-0 · Cited by 333
Glioma Stem Cells: A Midterm Exam
Stiles, C. D., & Rowitch, D. H. (2008) · Neuron · doi:10.1016/j.neuron.2008.05.031 · Cited by 330
The tumor-suppressor activity of PTEN is regulated by its carboxyl-terminal region
Georgescu, M.-M., Kirsch, K. H., Akagi, T., Shishido, T., & Hanafusa, H. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.18.10182 · Cited by 317
Oligodendroglioma: Toward Molecular Definitions in Diagnostic Neuro-Oncology
Reifenberger, G., & Louis, D. N. (2003) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/62.2.111 · Cited by 296
Self-citationEpigenetic PTEN Silencing in Malignant Melanomas without PTEN Mutation
Zhou, X.-P., Gimm, O., Hampel, H., Niemann, T., Walker, M. J., & Eng, C. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64627-5 · Cited by 278
Self-citationPouyan, A., Ghorbanlo, M., Eslami, M., Jahanshahi, M., Ziaei, E., Salami, A., Mokhtari, K., Shahpasand, K., Farahani, N., Meybodi, T. E., et al. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02267-0 · Cited by 271
Bigner, S. H., Matthews, M. R., Rasheed, B. K. A., Wiltshire, R. N., Friedman, H. S., Friedman, A. H., Stenzel, T. T., Dawes, D. M., McLendon, R. E., & Bigner, D. D. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65134-6 · Cited by 268
Perren, A., Komminoth, P., Saremaslani, P., Matter, C., Feurer, S., Lees, J. A., Heitz, P. U., & Eng, C. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64624-x · Cited by 266
Self-citationMolecular Genetic Analysis of Ependymal Tumors
Ebert, C., von Haken, M., Meyer-Puttlitz, B., Wiestler, O. D., Reifenberger, G., Pietsch, T., & von Deimling, A. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65158-9 · Cited by 257
Self-citationKurose, K., Zhou, X.-P., Araki, T., Cannistra, S. A., Maher, E. R., & Eng, C. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64681-0 · Cited by 252
Self-citationEnhanced radiation damage of tumor vasculature by mTOR inhibitors
Shinohara, E. T., Cao, C., Niermann, K., Mu, Y., Zeng, F., Hallahan, D. E., & Lu, B. (2005) · Oncogene · doi:10.1038/sj.onc.1208715 · Cited by 183
“PTEN is mutated in 20-30% of glioblastoma (Li et al., 1997; Duerr et al., 1998).”
BackgroundSelecting protein tyrosine phosphatases as drug targets
van Huijsduijnen, R. H., Bombrun, A., & Swinnen, D. (2002) · Drug Discovery Today · doi:10.1016/s1359-6446(02)02438-8 · Cited by 166
Fulci, G., Labuhn, M., Maier, D., Lachat, Y., Hausmann, O., Hegi, M. E., Janzer, R. C., Merlo, A., & Van Meir, E. G. (2000) · Oncogene · doi:10.1038/sj.onc.1203700 · Cited by 146
“%) malignant gliomas (WHO grades III and IV) (Table 1) consistent with previous reports (Chiariello et al., 1998; Duerr et al., 1998; Maier et al., 1997, 1998; Teng et al., 1997; Wang et al., 1997) and in six cases this was associated with mutations in the pten gene in the remaining allele (27.3”
ResultInfluentialChen, Y., Huang, W.-C., Sejourne, J., Clipperton-Allen, A. E., & Page, D. T. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.5272-14.2015 · Cited by 117
Kraus, J. A., Glesmann, N., Beck, M., Krex, D., Klockgether, T., Schackert, G., & Schlegel, U. (2000) · Journal of Neuro-Oncology · doi:10.1023/a:1006402614838 · Cited by 100
Krex, D., Mohr, B., Appelt, H., Schackert, H. K., & Schackert, G. (2003) · Neurosurgery · doi:10.1227/01.neu.0000093426.29236.86 · Cited by 42
Rickert, C. H., Riemenschneider, M. J., Schachenmayr, W., Richter, H., Bockhorn, J., Reifenberger, G., & Paulus, W. (2009) · Brain Pathology · doi:10.1111/j.1750-3639.2008.00199.x · Cited by 23
Metadata
- Authors
- Duerr, E.-M., Rollbrocker, B., Hayashi, Y., Peters, N., Meyer-Puttlitz, B., Louis, D. N., Schramm, J., Wiestler, O. D., Parsons, R., Eng, C., & von Deimling, A.
- Venue
- Oncogene
- Published
- 1998-04-30
- Volume
- 16
- Issue
- 17
- Pages
- 2259-2264
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2316897574
- Cited by
- 344
- References
- 0
- FWCI
- 20.90
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.